Sign in
8-K

Current Report

Aprea Therapeutics, Inc. Filed Acc 0001104659-20-106537

Delisting notice · Executive or director change · Regulation FD disclosure

  • Item 3.01 Notice of delisting or failure to meet a listing standard
  • Item 5.02 Departure or appointment of directors or officers
  • Item 7.01 Regulation FD disclosure

From the SEC's structured data for this filing

Loading tm2031204d1_8k.htm…